Ameriprise Financial Inc Astrazeneca PLC Transaction History
Ameriprise Financial Inc
- $415 Billion
- Q3 2025
A detailed history of Ameriprise Financial Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Ameriprise Financial Inc holds 5,707,561 shares of AZN stock, worth $510 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,707,561
Previous 5,046,992
13.09%
Holding current value
$510 Million
Previous $353 Million
24.16%
% of portfolio
0.11%
Previous 0.09%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...